Dr Julia Lai-Kwon is a Medical Oncologist and Health Services Researcher at Peter MacCallum Cancer Centre, Melbourne, Australia. She has previously trained at the Royal Marsden Hospital, United Kingdom, and the Melanoma Institute Australia in Sydney, Australia. Her clinical interests are melanoma and other cutaneous malignancies. Dr Lai-Kwon has research expertise in quality of life research, survivorship and patient-reported outcomes. She has presented nationally and internationally and published on the survivorship experience of people with metastatic cancers receiving immunotherapy and targeted therapy, quality of life issues in people with metastatic melanoma, and the use of patient-reported outcomes in clinical trials and routine care. She has completed a PhD under the supervision of Prof Michael Jefford, A/Prof Claudia Rutherford and A/Prof Stephanie Best on the co-design of a remote symptom monitoring for people receiving immune checkpoint inhibitors. Dr Lai-Kwon is an active member of the EORTC Quality Life Group, the International Society for Quality of Life Research (ISOQOL), and the Multinational Association for Supportive Care in Cancer (MASCC).